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Wnt proteins contain palmitoleic acid, an unusual
lipid modification. Production of an active Wnt signal
requires the acyltransferase Porcupine and depends
on the attachment of palmitoleic acid to Wnt. The
source of this monounsaturated fatty acid has not
been identified, and it is not known how Porcupine
recognizes its substrate and whether desaturation
occurs before or after fatty acid transfer to Wnt.
Here, we show that stearoyl desaturase (SCD) gener-
ates a monounsaturated fatty acid substrate that is
then transferred by Porcupine to Wnt. Treatment of
cells with SCD inhibitors blocked incorporation of
palmitate analogs into Wnt3a and Wnt5a and
reduced Wnt secretion as well as autocrine and
paracrine Wnt signaling. The SCD inhibitor effects
were rescued by exogenous addition of monoun-
saturated fatty acids. We propose that SCD is a
key molecular player responsible for Wnt biogenesis
and processing and that SCD inhibition provides an
alternative mechanism for blocking Wnt pathway
activation.
INTRODUCTION
Wnt proteins are a family of secreted signaling glycoproteins
that play major roles in coordinating tissue development and
cell fate determination during embryogenesis as well as tissue
homeostasis and oncogenesis in adults (Clevers, 2006; Logan
and Nusse, 2004). Activation of the canonical Wnt signaling
pathway stabilizes the transcriptional coactivator b-catenin,
which translocates to the nucleus, where it binds the T cell fac-
tor family of transcription factors and activates expression of
Wnt target genes. In order to signal correctly, Wnt proteins
need to be processed, modified and secreted. All Wnt ligands
contain a signal sequence at the N terminus, several N-glycosyl-
ation sites, and a cysteine-rich domain. In addition, Wnts
undergo a unique and essential lipid modification: the cis-D9-
monounsaturated fatty acid, palmitoleate (C16:1D9) is attached
to a highly conserved serine residue, corresponding to Ser1072 Cell Reports 4, 1072–1081, September 26, 2013 ª2013 The Au209 on Wnt3a (Takada et al., 2006). Lipid modification is
required for Wnt secretion, as mutants lacking the Ser modifica-
tion site are retained in the endoplasmic reticulum (ER) (Takada
et al., 2006) and are unable to interact with Wntless (Wls)
(Coombs et al., 2010; Herr and Basler, 2012), a conserved mem-
brane protein dedicated to the secretion of Wnt proteins. In
addition, palmitoleic acid plays a major structural role in medi-
ating the interaction of Wnt with its receptor Frizzled (Janda
et al., 2012; Kurayoshi et al., 2007). Thus, Wnt fatty acylation
is necessary in order to produce secreted, fully active Wnt
protein.
Genetic (Kadowaki et al., 1996; Tanaka et al., 2000; van den
Heuvel et al., 1993) and biochemical (Chen et al., 2009; Takada
et al., 2006) studies have identified Porcupine (Porcn) as the
acyltransferase responsible for lipid modification of Wnts. Porcn
is a member of the membrane-bound O-acyltransferase
(MBOAT) family (Hofmann, 2000) and is predicted to modify all
Wnt family members containing the conserved Ser 209 equiva-
lent (Takada et al., 2006). Wnt signaling is tightly linked to and
fine tuned by Porcn expression (Proffitt and Virshup, 2012),
placing Porcn as an attractive target for the development of
drugs that modulate Wnt pathway activity in Wnt-driven dis-
eases (Chen et al., 2009; Dodge et al., 2012; Proffitt et al.,
2013). A small-molecule inhibitor of Porcn, LGK974 (commer-
cially available as WntC59), has been developed and is currently
in early phase clinical trials.
Although a role for Porcn as a Wnt acyltransferase has been
established, it is not known how Porcn recognizes its fatty
acid substrate and why a monounsaturated fatty acid (MUFA)
is attached to Wnt proteins. All studies of Wnt acylation to
date have relied on labeling cells with the saturated fatty acid
(SFA) palmitate (Chen et al., 2009; Doubravska et al., 2011; Ko-
mekado et al., 2007; Takada et al., 2006; Willert et al., 2003), but
mass spectrometric analysis indicates that, under these condi-
tions, palmitoleate is the major fatty acid attached to Wnt (Ta-
kada et al., 2006). Thus, a mechanism must exist to convert
the SFA to a MUFA, either prior to or after transfer to Wnt pro-
teins. We hypothesized that stearoyl-CoA desaturase (SCD) is
responsible for generating the MUFA substrate for Porcn.
SCD, an ER-resident protein, is the rate-limiting enzyme in the
biosynthesis of MUFAs from SFA precursors. It introduces a
cis double bond at position 9 of palmitoyl-CoA (16:0) and
stearoyl-CoA (18:0) to generate palmitoleoyl-CoA (16:1) andthors
oleoyl-CoA (18:1), respectively (Miyazaki et al., 2006; Ntambi
and Miyazaki, 2004). MUFAs synthesized by SCD are then
used as major substrates for the synthesis of phospholipids, tri-
glycerides, and cholesteryl esters.
We assessed the role of SCD during Porcn-mediated Wnt
palmitoylation using a cell-based palmitoylation assay system.
Here, we show that SCD activity is required to generate a
MUFA substrate for Porcn and that Porcn transfers MUFAs,
but not SFAs, to Wnt3a. Furthermore, SCD inhibition blocks
Wnt3a secretion and rendersWnt inactive. These findings estab-
lish a role for SCD as an essential intermediate in Wnt protein
biogenesis and processing.
RESULTS
125I-Iodo-pentadecanoate Serves as a Probe for Porcn-
Dependent Wnt Fatty Acylation
To understand the mechanism by which Porcn transfers fatty
acids to Wnt proteins, cells were metabolically labeled with
125I-iodo-pentadecanoate (125I-IC15:0), a radio-iodinated analog
ofpalmitate.COS-1cellswerecotransfectedwithcomplementary
DNAs (cDNAs) encoding Myc-tagged Wnt3a and either empty
vector (pcDNA3.1) or FLAG-tagged Porcn and labeled with
125I-IC15:0 for 6 hr, a time window chosen to avoid potential
degradation of the radiolabeled fatty acid. Cells were lysed,
Wnt3a was immunoprecipitated, and radiolabel incorporation
was detected by phosphorimaging analysis after SDS-PAGE.
Wnt3a incorporated radiolabel whenPorcn, but not empty vector,
was coexpressed (Figure 1A). A similar result was obtained in
mouse L cells stably expressing Wnt3a (L-Wnt3a) (Figure 1B).
Wnt3a was radiolabeled when L-Wnt3a cells were transfected
with a vector expressing wild-type Porcn, but not with H341A
Porcn, an active site mutant (Figure 1B). Radiolabel incorporation
into Wnt3a was detectable in cells transfected with 200 ng of
Porcnplasmid, butwasmaximizedwhenhigher amountsofPorcn
were coexpressed. It is likely that, whenWnt3a is overexpressed,
higher levels of Porcn expression are required for efficient radio-
label incorporation during the 6 hr labeling time period. Porcn-
dependent radiolabeling of Wnt3a was inhibited when Ser209
was mutated, but mutation of Cys77 had no effect (Figure 1C),
consistent with the model that Wnt3a is lipidated only at Ser209
andnot atCys77 (Jandaetal., 2012;Willert et al., 2003).Moreover,
treatment of cells with the Porcn inhibitor WntC59 resulted in a
90% decrease in label incorporation into Wnt3a (Figure 1D), indi-
cating that fatty acylation was Porcn dependent.
To determine the nature of the linkage between the fatty acid
andWnt3a, we tested the lability of the modification to hydroxyl-
amine treatment. Thioester-linked fatty acids are sensitive to
NH2OH treatment at neutral pH, whereas oxyester linkages are
resistant. NH2OH released
125I-IC15:0 from the Src family kinase
Fyn, a thio-ester-linked palmitoylated protein, but not from
Wnt3a (Figure 1D), consistent with Wnt3a fatty acid attachment
occurring via an oxyester linkage.
Transfer of Fatty Acids ontoWnt3a by Porcn Is Sensitive
to Acyl Chain Length
Our laboratory has extensively used 125I-iodo-hexadecanoate
(IC16:0) as a probe to monitor protein palmitoylation in cellsCell Re(Alland et al., 1994; Buglino and Resh, 2008). Surprisingly, we
failed to detect 125I-IC16:0 incorporation into Wnt3a when Porcn
was coexpressed (Figure 1E). The 125I-iodine atom is equivalent
in size to a methyl group, making IC16 resemble a 17-carbon
fatty acid. We hypothesized that Porcn is sensitive to acyl chain
length and tested whether shorter fatty acids were substrates.
When COS-1 cells were incubated with the 125I-iodo-fatty acids
decanoic acid (IC10), dodecanoic acid (IC12), tridecanoic acid
(IC13), or pentadecanoic acid (IC15), radiolabeling of Wnt3a
occurred (Figure 1E). However, no incorporation of the longer
fatty acids stearic acid (IC18) or oleic acid (IC18:1) into Wnt3a
was evident, whereas Fyn was radiolabeled with these fatty
acids (Figure S1).
Although IC16:0was not incorporated intoWnt3a, low levels of
IC16:1 were detected in the presence of Porcn (Figure 1E). One
explanation for this finding is that the kink introduced by the cis
double bond makes the fatty acyl chain shorter and able to fit
into the active site of Porcn. Of note, 125I-iodo-pentadecenoic
acid (IC15:1) labeling of cells yielded a strikingly strong signal
(Figure 1E). These data suggest thatMUFAsmight be better sub-
strates for Porcn than their saturated fatty acid cognates, and
imply that a cellular fatty acid desaturase is required to generate
a suitable fatty acyl CoA substrate for Porcn.
SCD Inhibition Blocks 125I-IC15:0 Incorporation into
Wnt3a
SCD is themajor desaturase responsible for generating 16:1 and
18:1 MUFAs in the cell. We next tested the hypothesis that SCD
activity is required to produce the appropriate substrate for
Porcn-mediated acylation of Wnt. When L-Wnt3a cells express-
ing Porcn were labeled with 125I-IC15:0 in the presence of the
SCD inhibitors CAY10566 or A939572, Porcn-mediated label
incorporation into Wnt3a was dramatically reduced (Figures 2A
and 2B). A similar result was obtained in COS-1 cells coexpress-
ingWnt3a and Porcn (Figure 2C). Treatment with CAY10566 also
blockedPorcn-mediated acylation ofWnt5a, a noncanonicalWnt
ligand (Figure 2D), suggesting that the requirement for SCDactiv-
ity is conserved across Wnt family members. SCD inhibition had
no effect on the levels of Wnt3a, Wnt5a, or Porcn protein expres-
sion (Figures 2A–2D). Moreover, CAY10566 did not alter fatty
acylation of Sonic hedgehog (Shh), which is palmitoylated by
theMBOAT familymember Hhat, or Fyn (Figures 2E and 2F), indi-
cating that these reactions do not depend on SCD activity.
SCD is expressed as multiple isoforms (SCD1,2,3,4 in mice;
SCD1,5 in humans), which share >80% sequence identity but
are differentially expressed and regulated (Flowers and Ntambi,
2008; Paton and Ntambi, 2009). Quantitative PCR analysis re-
vealed that mouse L-Wnt3a cells primarily express SCD1 and
SCD2 messenger RNAs (mRNAs) (average mRNA expression/
HPRT ± SEM: SCD1, 3.07 ± 0.04; SCD2, 10.12 ± 0.16; SCD3,
0.002 ± 0.07; SCD4, 0.001 ± 0.05). Treatment of L-Wnt3a cells
with SCD1 siRNA had no effect on Wnt3a fatty acylation,
whereas addition of both SCD1- and SCD2-directed siRNAs
reduced Porcn-mediated labeling of Wnt3a with 125I-IC15:0 (Fig-
ure S2). Since both SCD1 and SCD2 are capable of generating
16:1 from 16:0, it is likely that SCD1 and SCD2 are responsible
for Wnt3a acylation in L-Wnt3a cells. These findings demon-
strate that SCD activity is required for Wnt acylation by Porcn,ports 4, 1072–1081, September 26, 2013 ª2013 The Authors 1073
Figure 1. Reconstitution of Wnt3a Palmitoylation by Porcn in Cells
(A and C) COS-1 cells were cotransfectedwith plasmids encodingMyc-taggedWnt3a constructs and either empty vector (pcDNA3.1) or FLAG-tagged Porcn and
labeled with 40 mCi of 125I-IC15:0 for 6 hr. Cell lysates were immunoprecipitated (IP) with anti-Myc antibody and analyzed by SDS-PAGE and phosphorimaging
(top panels) or western blotting (WB) with anti-Myc antibodies (middle panels). Porcn expression was detected by IP and WB with anti-FLAG antibodies (lower
panels). (A) The amount of each plasmid transfected (1 mg or 3 mg) is indicated. Gel images represent duplicate samples.
(B) L-Wnt3a cells expressing FLAG-tagged Porcn constructs were treated and analyzed as in (A). E.V., empty vector.
(D) COS-1 cells were labeled as in (A). Wnt3a and Fyn immunoprecipitates containing 125I-IC15:0 were treated with 1 M Tris or NH2OH (pH 7.0) for 1 hr at room
temperature and analyzed as in (A). ForWntC59 experiments, cells were treated with DMSO or 10 nM of drug 3 hr prior to label addition. Phosphorimaging signals
(legend continued on next page)
1074 Cell Reports 4, 1072–1081, September 26, 2013 ª2013 The Authors
Figure 2. SCD Activity Is Required for Wnt Fatty Acylation
L-Wnt3a cells (A and B) or COS-1 cells (C–F) expressing the indicated constructs were incubated for 3 hr in media containing CAY10566 or A939572 and then
labeled with 40 mCi of 125I-IC15:0 (A–D and F) or 125I-IC16:0 (E and F) for 6 hr. Cell lysates were analyzed as in Figure 1. In the lower panels (A, B, E, and F), total cell
lysates (TCL) were analyzed directly by WB using the indicated antibodies. See also Figure S2.and suggest that Porcn transfers MUFAs, but not saturated fatty
acids, to Wnt family members.
Exogenous Addition of MUFAs Bypasses the
Requirement for SCD
To test the hypothesis that the authentic cellular substrate for
Porcn is a MUFA, cells were labeled with the cis-D9-MUFAwere normalized to protein levels; NH2OH and WntC59 sensitivity are expressed
performed two times in duplicate.
(E) COS-1 cells were cotransfected with the indicated plasmids, labeled with 40 mC
images represent duplicate samples.
See also Figure S1.
Cell Reiodo-pentadecenoate (IC15:1). 125I-IC15:1 was incorporated
into wild-type, but not S209A, Wnt3a (Figure 3A). No radiolab-
eling of Wnt3a occurred in cells expressing H341A Porcn or
Hhat, the Shh acyltransferase (Figure 3B). These data indicate
that Wnt3a acylation with the IC15:1 MUFA is Porcn depen-
dent. In stark contrast to the results with IC15:0, treatment
of COS-1 or L-Wnt3a cells expressing Porcn with CAY10566as percentage of Tris- or DMSO-treated controls ± SEM. The experiment was
i of the indicated radio-iodinated fatty acids for 6 hr, and analyzed as in (A). Gel
ports 4, 1072–1081, September 26, 2013 ª2013 The Authors 1075
Figure 3. The SCD Requirement Is Bypassed by Exogenous Addition of MUFAs
(A–D) COS-1 cells expressing Myc-taggedWnt3a and/or FLAG-tagged Porcn or hemagglutinin-tagged Hhat constructs (A, B, and D) or L-Wnt3a cells expressing
FLAG-tagged Porcn constructs (C) were labeledwith 125I-IC15:1 ± 100 nMCAY10566 orWntC59. Samples were analyzed as in Figure 1. (D) Gel images represent
duplicate samples.
(E) A schematic model illustrating successive Wnt processing by SCD and Porcn.
See also Figure S3.or with SCD-1 and SCD-2 directed small interfering RNAs
(siRNAs) had no effect on incorporation of either 125I-IC15:1
(Figures 3C and 3D; Figure S2) or 125I-IC16:1 (Figure S3) into
Wnt3a. Thus, the requirement for SCD can be bypassed by
directly providing a MUFA substrate to cells expressing Porcn
and Wnt3a.1076 Cell Reports 4, 1072–1081, September 26, 2013 ª2013 The AuSCD Inhibition Reduces Wnt3a Secretion and Signaling
Activity
If SCD is required for Porcn-mediated attachment of endoge-
nous MUFAs to Wnt proteins, defects in Wnt3a secretion and
signaling should occur in cells treated with SCD inhibitors.
When L-Wnt3a cells were treated with CAY10566 or Wnt C59,thors
Wnt3a secretion into the media was decreased by 50% and
90%, respectively, compared to DMSO-treated controls (Fig-
ure 4A). Treatment with CAY10566 had no effect on secretion
of Shh (Figure S4), indicating that gross aberrations in the secre-
tory pathway were not occurring. Decreased Wnt3a levels in the
media were confirmed using a luciferase-based reporter system
of Wnt signaling, Super TOP-FLASH (STF). L-Wnt3a cells were
treated with 10 nM or 25 nM CAY10566 or 10 nM WntC59. The
conditioned media (CM) was used to stimulate HEK293T cells
coexpressing STF and Renilla luciferase (RL) reporter plasmids.
L-Wnt3a CM from DMSO-treated cells caused 100-fold induc-
tion in signaling activity, whereas CM from cells treated with
either CAY10566 or WntC59 yielded 60%–90% lower activity
(Figure 4B).
The STF system was also used to examine the effect of SCD
inhibition on paracrine and autocrine Wnt signaling activity. To
measure paracrine signaling, L-Wnt3a cells were cocultured
with HEK293T cells coexpressing STF and RL. Treatment with
CAY10566 resulted in a50% decrease inWnt signaling activity
compared to DMSO-treated controls (Figure 4C). Of note, this
signaling defect was rescued by supplying exogenous palmito-
leic acid to the cocultures, whereas the inhibitory effect of Wnt
C59 could not be rescued (Figure 4C). Autocrine signaling activ-
ity, as measured in HEK293T cells expressing STF, RL, and
Wnt3a, was also inhibited when cells were treated with
CAY10566 or Wnt C59 (Figure 4D). To exclude the possibility
that CAY10566 impairs the ability of reporter cells to respond
to Wnt proteins, the drug was added directly to the CM from
L-Wnt3a cells, and then CM containing drug was added to
HEK293T cells expressing STF and RL. Signaling activity was
not reduced by the presence of CAY10566 in the CM (Figure 4E).
Finally, treatment of cells with either CAY10566 or WntC59
inhibited Wnt signaling pathway components, as evidenced by
decreased levels of cytosolic b-catenin and phosphorylated
Dishevelled (Figure 4F). Taken together, these data indicate
that SCD inhibition blocks Wnt secretion as well as autocrine
and paracrine signaling activity.
DISCUSSION
The data presented in this study strongly suggest that SCD is
responsible for generating the MUFA substrate for Porcn and
that conversion to an unsaturated fatty acid occurs prior to trans-
fer by Porcn. Depletion of SCD1 and SCD2 or treatment of cells
with two different, highly specific SCD inhibitors blocked acyla-
tion of Wnt3a when cells were incubated with radiolabeled satu-
rated fatty acids. Moreover, the inhibitory effect of CAY10566 on
Wnt3a labeling could be completely rescued when cells were
directly supplied with the MUFAs C15:1 or C16:1. These findings
are consistent with the following series of events: (1) palmitate
enters the cell and is converted to palmitoyl CoA; (2) SCD con-
verts palmitoyl CoA to palmitoleoyl CoA; and (3) Porcn uses pal-
mitoleoyl CoA as a substrate and transfers the unsaturated fatty
acid to Wnt (Figure 3E).
Iodo-fatty acids have served as versatile tools to monitor a
wide variety of fatty acylation reactions, including N-myristoyla-
tion, S-palmitoylation, and N-palmitoylation (Alland et al., 1994;
Buglino and Resh, 2008; Liang et al., 2004). A notable featureCell Reof these reagents is their limited metabolic interconversion to
longer or shorter fatty acid species (Peseckis et al., 1993). We
have shown that palmitoylated proteins such as Src family
kinases, GAP43, and Shh are efficiently acylated with 125I-
IC16:0. However, this fatty acid was not a substrate for Porcn,
presumably because it is sterically similar to a 17-carbon fatty
acid. Longer-chain fatty acids such as IC18:0 and IC18:1 were
not incorporated into Wnt3a, but fatty acids with shorter chains
were transferred. It is important to note that cell-based labeling
assays provide only a qualitative measure of fatty acid substrate
specificity, since we do not know the size of the nonradioactive
pool of these fatty acids in the cytosol or in the ER lumen, where
Wnt protein acylation occurs. Thus, it is not possible to quantita-
tively compare the stoichiometry of incorporation of fatty acids of
varying lengths into Wnt. Nonetheless, it is reasonable to
conclude that Porcn exhibits chain-length sensitivity, as it is
unable to transfer fatty acids longer than 16 carbons to Wnt
proteins. The data presented in Figure 3 suggest that metabolic
labeling with 125I-IC15:1 provides a robust, accurate, and direct
readout of Porcn activity in the cell.
Palmitoleic acid is a rare fatty acid and its distribution in cells is
highly regulated (Cao et al., 2008). It is not known why Wnt pro-
teins are modified with palmitoleate instead of palmitate, which
is more abundant and is the fatty acid typically attached to
‘‘palmitoylated’’ proteins (Resh, 2012). The bent conformation
of palmitoleate may provide an appropriate three-dimensional
conformation for interaction of Wnt with Wls (Herr et al., 2012),
thereby regulating Wls-dependent packaging of Wnt into exo-
somes and Wnt secretion. A bent conformation may also assist
in insertion of palmitoleate into the hydrophobic groove of Friz-
zled that binds Wnt (Janda et al., 2012). Thus, the active site of
Porcn may have evolved to accommodate a cis-unsaturated
fatty acid. Our finding that shorter fatty acids, presumably via
their cis-unsaturated forms, are incorporated into Wnt3a sug-
gests that Porcn generates a varied population of Wnt proteins
with different acyl groups. Differentially lipidated Wnts may
exhibit different binding affinities for Frizzled and/or different sta-
bilities and secretion, which could shape the morphogen
gradient and thereby regulate signaling in vivo. We speculate
that the intracellular pool of fatty acylCoAs and/or the MUFA/
SFA ratio dictate the identity of the fatty acid attached to Wnt
proteins. It is possible that when palmitoleate levels are limiting,
Porcn utilizes shorter fatty acid substrates. This could link fatty
acid metabolism and Wnt signaling activity and suggests that
Wnt signaling might respond to changes in the metabolic state
of the cell.
As a result of gene duplication during evolution, different spe-
cies contain different numbers of SCD genes and express
different numbers of SCD isoforms (Castro et al., 2011). In
mice, all four SCD isoforms share >80% amino acid sequence
identity, all contain the 8-histidine motif required for catalysis,
and all exhibit desaturase activity (SCD1, SCD2, andSCD4desa-
turate palmitoyl-CoA and stearoyl-CoA; SCD3 activity is
restricted to palmitoyl-CoA; Miyazaki et al., 2006). Human
SCD1 shares 85% homology with mouse Scd1–Scd4, whereas
SCD5 shares limited sequence identity (65%); both isoforms
exhibit desaturase activity. At least two isoforms, SCD1 and
SCD2, have been shown to be inhibited by CAY10566 (Masudaports 4, 1072–1081, September 26, 2013 ª2013 The Authors 1077
Figure 4. SCD Inhibition Reduces Wnt3a Secretion and Signaling
(A) L-Wnt3a cells were grown in the presence of the indicated drugs for 48 hr. The conditioned media was concentrated and analyzed along with the TCL by WB
using anti-Wnt3a antibody. See also Figure S4.
(B) L-Wnt3a cells were cultured as in (A). The conditioned media was used to stimulate HEK293T reporter cells expressing STF and RL for 24 hr. The y axis
represents absolute values for luciferase activity, after adjusting for RL and FOP-Flash activity. The experiment was performed two times in triplicate; a
representative image is shown.
(C) L-Wnt3a cells were cocultured with HEK293T reporter cells and grown for 24 hr in the presence of DMSO, CAY10566, orWntC59. A total of 100 mMpalmitoleic
acid was added to the culture medium where indicated. Luciferase activity was measured 24 hr after stimulation, normalized to RL and FOP-Flash activity, and
expressed as a percentage of DMSO-treated controls; bars represent mean ± SEM (n = 3).
(legend continued on next page)
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et al., 2012), but given the high degree of conservation, especially
in the catalytic region, it is likely that all isoforms are susceptible
to pharmacologic inhibition. SCD1 is ubiquitously expressed in
themouse, while the other isoforms exhibit predominant expres-
sion in brain (SCD2), skin (SCD3), and heart (SCD4). Human
SCD1 is also ubiquitously expressed, while SCD5 is most abun-
dant in brain and pancreas. However, many tissues expressmul-
tiple SCD isoforms, and one isoform can partially compensate for
loss of the other, which likely explains why, despite their meta-
bolic defects, SCD1/ and SCD2/ mice are viable (Miyazaki
et al., 2001, 2005). siRNA-mediated knockdown of both SCD1
and SCD2 was required to reduce radiolabel incorporation into
Wnt3a in IC15:0 labeled cells, indicating that both isoforms
generate MUFAs for Wnt acylation in mouse L-Wnt3a cells. It is
possible that other SCD isoforms also contribute, especially in
tissues where the other isoforms are differentially expressed.
SCD1 has recently gained prominence as a target for regu-
lating stem cell and cancer cell growth. For example, a newly
developed SCD1 inhibitor, PluriSIn #1, selectively eliminates
human pluripotent stem cells while sparing progenitor and differ-
entiated cells (Ben-David et al., 2013). SCD1 expression levels
are upregulated in colon, breast, prostate, and lung cancers
and inhibition of SCD blocks cell proliferation and tumor growth
(Igal, 2010; Roongta et al., 2011). Potential mechanisms to
explain how SCD1 inhibition blocks cancer cell proliferation
include attenuation of AKT signaling and induction of senes-
cence and apoptosis (Igal, 2010). Given the well-documented
roles of Wnt in regulating stem cell and tumor cell proliferation
and our findings on the requirement for SCD in Wnt processing,
we suggest that inhibition of Wnt protein acylation and function
might be responsible, in part, for the inhibitory effects observed
in these studies. Two recent studies are consistent with this
hypothesis. Mauvoisin et al. reported that depletion of SCD1 in-
hibits b-catenin accumulation and activity as well as the growth
and invasiveness of breast cancer cells, leading these authors to
suggest that SCD inhibition might impact signaling through Wnt
acylation (Mauvoisin et al., 2013). In another study, constitutive
overexpression of SCD5 in neuronal cells increased MUFA pro-
duction, Wnt5a secretion into the media, and noncanonical
Wnt5a signaling (Sinner et al., 2012). However, opposite effects
on Wnt7a were observed: SCD5 overexpression decreased
Wnt7b expression and signaling, findings that are not readily
reconcilable with the effects we observed for Wnt3a. It is also
possible that other signaling pathways are affected, directly or
indirectly by alterations in SCD levels. In summary, the current
report provides a biochemical mechanism documenting how
SCD activity controls Wnt biogenesis and pathway activation.
Our findings suggest that SCD inhibition may present an alterna-
tive method of blocking Wnt pathway activation in normal and
disease states.(D) HEK293T cells expressing Wnt3a, STF, and RL were grown ± 10 nM CAY10
stimulation, normalized to RL and FOP-Flash activity, and expressed as a perce
(E) DMSO or 25nM CAY10566 was added to L-Wnt3a CM collected from a 48 hr
fresh media (not incubated with L-Wnt3a cells) was added. The y axis represen
activity.
(F) HEK293T cells expressing Wnt3a were treated with CAY10566 or WntC59 for
The cytosolic fraction from a second set of cells was probed for b-catenin. All er
Cell ReEXPERIMENTAL PROCEDURES
Reagents and Antibodies
Rabbit polyclonal anti-Wnt3a and rabbit polyclonal anti b-catenin were pur-
chased from Cell Signaling Technology. Rat polyclonal anti-Wnt3a, goat poly-
clonal anti-Shh (N-19), rabbit polyclonal anti-Shh (H-160), and protein A/G plus
agarose were purchased from Santa Cruz Biotechnology. Mouse monoclonal
anti-FLAG M2 and palmitoleic acid were purchased from Sigma-Aldrich. Anti-
Fyn serum was generated as reported previously (Liang et al., 2001). Small
molecule compounds were purchased from Cayman Chemical (CAY10566),
BioVision (A939572), and Cellagen Technology (Wnt C59). SiRNA duplexes
against mouse Scd1 were purchased from Origene (Cat# SR411990). A smart
pool siRNA against mouse Scd2 was obtained from Dharmacon/Thermo
Scientific (Cat# L-045507-01-0005).
Plasmids, Cell Culture, and Transfection
Cloning of Wnt3a-Myc, Shh, Hhat-HA, and Fyn cDNAs into mammalian
expression vectors has been described elsewhere (Buglino and Resh, 2008).
N-terminal FLAG-tagged Porcn cDNAwas generated from amurinePorcupine
clone in pcDNA3.1 (a gift from Dr. Joseph Goldstein, UT Southwestern).
COS-1, HEK293T, L, and L-Wnt3a cells were obtained from ATCC. Super 8
3 TOP/FOP FLASH and pRL-TK plasmids were a gift from Dr. Anthony MC
Brown (Weill Cornell Medical College). COS-1, HEK293T, and L-cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM)/10% fetal bovine
serum (FBS). L-Wnt3a cells were grown in DMEM/10% FBS and 0.5g/l Genet-
icin. Cells were transfected with Lipofectamine 2000 (Invitrogen) in 100 mm
plates. When using siRNA, L-Wnt3a cells in 60 mm plates were cotransfected
with 1 mg FLAG-Porcn plasmid and 20 nM siSCD1 and/or siSCD2.
Synthesis of 125I-Iodo-Fatty Acids
Iodo-decanoate, iodo-dodecanoate, iodo-tridecanoate, iodo-pentadeca-
noate, iodo cis-9-pentadecenoic acid, and iodo cis-9-hexadecenoic acid
were synthesized by the Sloan-Kettering Organic Synthesis Core Lab. Conver-
sion into 125I-iodo-fatty acids was performed using 125I-NaI (Perkin Elmer)
(Alland et al., 1994; Peseckis et al., 1993).
Metabolic Labeling of Cells with Radio-Iodinated Fatty Acid Analogs
COS-1 cells transfected with plasmids encoding Wnt3a-myc and FLAG-
Porcn, or L-Wnt3a cells transfected with 6 mg FLAG-tagged Porcn plasmid ±
20 nM of siSCD1 and/or siSCD2, were incubated in DMEM containing 2% dia-
lyzed FBS for 3 hr. When indicated, CAY10566, A939572, or WntC59 was
added. 40 mCi of the indicated radio-iodinated fatty acid was added and cells
were grown for 6hrs at 37C. Cell lysates (Buglino and Resh, 2008) were
immunoprecipitated with 5 ml of the indicated antibody and 60 ml of protein
A/G-agarose for 16 hr at 4C, eluted in sample buffer containing 60 mM dithio-
threitol, and electrophoresed on 12.5% SDS-PAGE gels. When indicated,
immunoprecipitates were treated with 40 ml of 1 M Tris or 1 M NH2OH
(pH 7.0) for 1hr at room temperature and eluted with 53 sample buffer. Radio-
label incorporation intoWnt3a,Wnt5a, Shh, or Fynwas detected on a Fuji FLA-
700 phosphorimager and quantified using ImageGauge software. Protein
expressionwas detected bywestern blotting (WB) using enhanced chemilumi-
nescence (Thermo Scientific) and quantified with Image J software.
Secretion Assays
L-Wnt3a cells were transfected with 6 mg of FLAG-Porcn plasmid. Cells were
switched to DMEM/2% dialyzed FCS and either DMSO, Wnt C59, or
CAY10566 24 hr posttransfection and grown for 48 hr. Conditioned media566 or 10 nM WntC59 for 24 hr. Luciferase activity was measured 24 hr after
ntage of DMSO-treated controls; bars represent mean ± SEM (n = 3).
culture. This mixture was then added to HEK293T reporter cells. As a control,
ts absolute values for luciferase activity, after adjusting for RL and FOP-Flash
24 hr. Lysates were collected and probed by WB with the indicated antibodies.
ror bars are ± SEM.
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was cleared by centrifugation at 5003 g for 5 min and concentrated to a final
volume of 500 ml using 10,000 molecular weight cutoff centrifugal devices
(Sartorius Stedim Biotech). The amount of Wnt3a in the media was analyzed
by WB.
Wnt Signaling Activity Assays
To measure paracrine Wnt signaling activity, HEK293T cells in 100 mm plates
were transfected with 3 mg of STF or Super FOP and 0.3 mg pRL-TK, and 24 hr
posttransfection, cells were cocultured in six-well plates with L-Wnt3a cells or
L cells expressing Wnt3a and Porcn at a 3:1 ratio (L-Wnt3a:293T) in the pres-
ence of the indicated drugs for 1–2 days.Wnt3a pathway activity was detected
using a dual-luciferase reporter assay (Promega). FL and RL activity were re-
corded as relative luciferase units using a Veritas microplate luminometer
(Promega). For autocrine Wnt signaling, HEK293T cells grown in 100 mm
plates were cotransfected with plasmids encoding Wnt3a-myc, STF, or Super
FOP Flash and RL. Then 24 hr posttransfection, cells were seeded in six-well
plates at a density of 0.5 3 106 cells per well in DMEM/2% dialyzed fetal calf
serum (FCS) andDMSO,CAY10566, orWntC59. Cells were grown for 24–48 hr
and luciferase activity was measured.
To detect markers of Wnt pathway activation, HEK293T cells grown in
100 mm plates were transfected with 1 mg Wnt3a-myc plasmid. Then 24 hr
posttransfection, cells were switched to DMEM containing 2% dialyzed FCS
and either DMSO, 10 nM Wnt C59, or 25 nM CAY10566 and cultured for
24 hr. Cells were lysed in 13RIPA containing protease and phosphatase inhib-
itors for 10min at 4C. Lysateswere cleared by centrifugation at 14,000 rpm for
30 min and analyzed by SDS-PAGE and WB. A parallel set of plates was sub-
jected to cell fractionation to obtain the cytosolic pool of b-catenin.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
article online at http://dx.doi.org/10.1016/j.celrep.2013.08.027.
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